MICHAEL HUDACK: Open Payments
NPI 1174712145 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 20 payments from 12 companies in 2025. Trend: 2023 $74 · 2024 $701 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $318 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Tanabe Pharma America, Inc. | 1 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 3 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| Corcept Therapeutics | 1 | $18 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: REZDIFFRA, SKYRIZI, VIBERZI, Radicava, VYEPTI, VOQUEZNA, EOHILIA, ISTURISA.
Industry payments across FL — which companies pay providers there.
